Senior Director, Medical Excellence Strategic Programs at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Senior leadership experience within Medical Affairs or related global medical strategy/operations roles
Expertise in driving capability development, process excellence, and strategic alignment across global Medical Affairs organizations
Strong partnership skills across therapeutic areas, regions, and functions (e.g., Digital, Insights and Analytics, Scientific Communications, Medical Affairs Technology)
Deep knowledge of Medical Affairs engagement strategies, including Field Medical, Medical Information, and Digital/Omnichannel platforms
Ability to design, implement, and continuously improve frameworks, tools, methodologies, templates for engagement planning, execution, and measurement
Experience in operationalizing omnichannel approaches aligned with scientific and compliance standards
Proven track record in process and capability development, continuous improvement of processes, tools, and operating models

Responsibilities

Partner with the Medical Excellence Leadership team to define and execute the global Medical Excellence strategy
Lead initiatives that elevate consistency, quality, and impact of medical engagement planning, execution, and measurement
Drive continuous improvement of Medical Affairs processes, tools, and operating models
Collaborate with GMSO teams (Digital, Insights and Analytics, Scientific Communications and Content Strategy, Medical Affairs Technology) to build programs leveraging cross-capability connections
Partner with Regional Medical Excellence to ensure consistent deployment and execution across regional teams
Develop and deploy frameworks, tools, and support to help local/regional medical teams translate global medical strategy into effective engagement plans
Define standard methodologies, templates, and tools optimizing planning, execution, and measurement across engagement channels (Field Medical, Medical Information, Digital, etc.)
Collaborate with Channel Leads (digital, personal, print) to establish principles for channel selection, integration, and sequencing
Support country and regional teams in operationalizing omnichannel approaches aligned with scientific and compliance standards
Identify and implement process and capability development initiatives

Skills

Medical Affairs

Process Excellence

Capability Development

Strategic Alignment

Framework Design

Tool Implementation

Scientific Excellence

Operational Excellence

Cross-functional Collaboration

Therapeutic Areas

Global Operations

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free